Program Details
Information about medical programs provided by each healthcare institution, including treatment details, schedules, etc.,
- medical treatment
- myeloma・leukemia
- immunotherapy
Hematology Treatment Program (Osaka International Cancer Institute)
We are committed to achieving the best possible outcomes—and ultimately a cure whenever possible—for all hematologic malignancies and complex hematologic disorders, by providing the most appropriate and state-of-the-art treatments.
We strive to cure blood cancers and complex blood diseases with the best and most advanced treatments. With our 33-bed sterile ward, we specialise in chemotherapy, haematopoietic cell transplants, and immuno-cell therapy for blood cancers.
- Providing Medical Institution
-
Osaka Prefectural Hospital Organization Osaka International Cancer Institute
〒540-0008https://oici.jp/
3-1-69, Otemae, Chuo-ku, Osaka-City, Osaka- Departments
-
- Internal medicine
- surgery
- Pediatrics
- Gynecology
- Specialty
- Cancer, Tumors
- Eligibility Criteria/Exclusions for Treatment
- Medical information in Japanese or English.
If translated, it must be by a medical translator.
Various laboratory and imaging data (including findings).
Cancer screening is not generally carried out.
- Remarks
- ・Acute leukaemia
・Chronic leukaemia
・Malignant lymphoma
・Myeloma
・Myelodysplastic syndrome
・Hemolytic anemia
・Thrombocytopenic purpura
- No.
- K0885-01
- Precautions / Contraindications
- All relevant information on medical treatment, including treatment, is provided to patients in order for them to fully understand about their medical treatment, and to choose their own treatment method and engage in treatment of their own volition.
Patients are informed in advance about the name of the disease, its condition and prognosis.